IQVIA Earnings
NYSE: IQVHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
Next earnings date
Tue, Oct 27, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$2.95
IQVIA earnings summary
IQVIA is scheduled to report Sep/2026 earnings on Oct 27, 2026 before the market opens, with analysts expecting EPS of $2.95. In its most recent report on May 5, 2026 (Q1 2026), IQV posted EPS of $1.61. Revenue for the quarter was $4.15 billion.
Quarterly EPS is up 15.0% from the same quarter a year earlier. Across the last 16 reports, IQV shares moved an average of 3.8% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
IQV earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| May 5, 2026 | — | $1.61 | — | -5.4% |
| Feb 17, 2026 | — | $2.97 | — | +8.0% |
| Oct 28, 2025 | — | $1.93 | — | -2.8% |
| Jul 22, 2025 | — | $1.54 | — | -8.4% |
| May 6, 2025 | — | $1.40 | — | -4.1% |
| Feb 13, 2025 | — | $2.41 | — | -1.2% |
| Oct 31, 2024 | — | $1.55 | — | +4.8% |
| Jul 22, 2024 | — | $1.97 | — | +0.9% |
| May 2, 2024 | — | $1.56 | — | +4.8% |
| Feb 15, 2024 | — | $2.54 | — | +3.6% |
| Nov 1, 2023 | — | $1.63 | — | -0.6% |
| Aug 1, 2023 | — | $1.59 | — | +1.3% |
| Apr 28, 2023 | — | $1.53 | — | +0.2% |
| Feb 15, 2023 | — | $1.21 | — | -4.6% |
| Oct 27, 2022 | — | $1.49 | — | -2.0% |
| Jul 22, 2022 | — | $1.34 | — | +8.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.